查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530408

癌症治疗设施市场规模、份额、趋势分析报告：按治疗、癌症类型、提供者、地区和细分市场预测，2024-2030 年

Cancer Treatment Facilities Market Size, Share, & Trends Analysis Report By Treatment (Cancer Surgery, Chemotherapy), By Cancer Type (Blood Cancer, Breast Cancer), By Provider, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

癌症治疗设施市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球癌症治疗设施市场规模预计将达到787.1亿美元，预测期内复合年增长率为7.75%。

市场成长的主要驱动力包括增加患者援助计划、政府提高癌症意识的措施以及对个人化医疗的需求不断增加。

全球女性乳癌等肿瘤的盛行率不断上升，使得乳癌成为医疗保健提供者的重要专业和投资目标。对先进诊断技术、个人化医疗和客製化治疗方法的需求预计将改善患者的治疗结果和生存率，并在预测期内推动该行业的成长。例如，2024 年 1 月，米高梅医疗保健公司开设了 B 诊所，为患者提供针对所有类型乳房健康问题的全面、先进的治疗，从良性肿块和囊肿到肿瘤和重组。

此外，免疫疗法最近已成为某些癌症治疗的重要组成部分。免疫疗法是一种日益先进的治疗方法，可以透过针对癌症特异性标靶来增强免疫系统对抗癌症的能力。因此，服务供应商正在加强其策略性倡议，以增加其在市场上的影响力，预计这将成为未来几年成长的驱动力。 2023 年 1 月，BioNTech SE 将与英国政府合作，到年终为多达 10,000 名患者提供工程化 mRNA 免疫疗法的临床试验。我们也专注于提供感染疾病疫苗并进行投资以扩大我们在英国市场的足迹。

此外，一些行业参与者正在推出新服务以提高渗透率。例如，2024 年 3 月，坦帕总医院在坦帕主院成立了 TGH 癌症研究所一期癌症研究中心。这一期癌症研究中心的目的是为癌症患者提供前沿研究与富有同情心的综合护理相结合的机会。

癌症治疗设施市场报告亮点：

  • 在治疗方面，癌症手术细分市场占据主导地位，2023年销售份额为34.12%。机器人手术技术的发展和日益普及对该领域的发展产生了重大影响。然而，化疗服务在预测期内成长最快。
  • 根据癌症类型，血癌细分市场在 2023 年占据最大的收益占有率。这一增长是由于全球主要企业越来越多地参与血癌治疗的研发而推动的。
  • 按提供者划分，由于先进的肿瘤诊断和治疗能力，医院部门在 2023 年占据了最大的收益占有率。
  • 由于癌症发病率上升、个人化医疗需求增加以及医疗基础设施不断发展等因素，亚太地区在 2023 年占据市场主导地位。
  • 2024年5月，HCG（Healthcare Global Enterprise）在北班加罗尔开设了新的癌症治疗中心，总合增加了125个病床。这些地理位置优越的设施提供全方位的先进癌症护理，从诊断到个人化治疗计划。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 波特五力分析
    • PESTLE分析

第 4 章 癌症治疗设施市场：按治疗分类的估计和趋势分析

  • 2023 年和 2030 年按治疗方法市场占有率
  • 治疗细分仪表板
  • 2018 年至 2030 年市场规模以及按处理和趋势分析进行的预测
  • 骨髓移植
  • 化疗
  • 放射治疗
  • 荷尔蒙疗法
  • 免疫疗法
  • 癌症手术

第五章癌症治疗设施市场：按癌症类型的估计和趋势分析

  • 2023 年和 2030 年按癌症类型分類的市场占有率份额
  • 按癌症类型细分仪表板
  • 2018-2030年按癌症类型分類的市场规模及预测与趋势分析
  • 血癌
  • 乳癌
  • 摄护腺癌
  • 消化道癌症
  • 妇科癌症
  • 呼吸道/肺癌
  • 其他癌症类型

第六章癌症治疗设施市场：提供者的估计和趋势分析

  • 2023 年和 2030 年按提供者分類的市场占有率
  • 按提供者细分仪表板
  • 2018-2030 年市场规模、提供者预测与趋势分析
  • 癌症中心
  • 医院

第七章癌症治疗设施市场：区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 2018-2030 年北美癌症治疗设施市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030 年欧洲癌症治疗设施市场估计与预测
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太地区癌症治疗设施市场估计与预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲癌症治疗设施市场估计与预测，2018-2030 年
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 中东和非洲癌症治疗设施市场估计和预测，2018-2030 年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 参与者概览
  • 公司市场分析
  • 公司分类
  • 策略规划
  • 公司简介/名单
    • Compass Oncology
    • American Oncology Institute
    • Mayo Foundation for Medical Education and Research（MFMER）
    • HCA International Limited
    • The Royal Marsden
    • National Cancer Instituteat the National Institutes of Health
    • Apollo Hospitals Enterprise Ltd.
    • Kokilaben Dhirubhai Ambani Hospital
    • HEALTHCARE GLOBAL ENTERPRISES LIMITED
    • The Johns Hopkins Hospital
    • Tata Memorial Centre.
Product Code: GVR-4-68040-374-3

Cancer Treatment Facilities Market Growth & Trends:

The global cancer treatment facilities market size is anticipated to reach USD 78.71 billion by 2030 and is anticipated to grow at a CAGR of 7.75% over the forecast period, according to a new report by Grand View Research, Inc. Key drivers of market growth include increasing patient assistance programs, government initiatives for cancer awareness, and the increasing demand for personalized medicine.

The increasing prevalence of neoplasm, such as breast cancer, among women worldwide makes it a significant area of specialization and investment for healthcare providers. The demand for advanced diagnostic technologies, personalized medicine, and tailored treatment approaches enhances patient outcomes and survival rates and is expected to drive the growth of the segment during the forecast period. For instance, in January 2024, MGM Healthcare launched Clinic B to support and help patients with comprehensive and advanced treatment for all types of breast health problems - ranging from benign lumps and cysts to tumors and reconstruction.

Furthermore, immunotherapy has become an important part of treating some types of cancer in recent years. Immunotherapy is an advanced type of treatment that is growing its presence due to its ability to enhance the immune system's ability to fight cancer by directing it toward cancer-specific targets; this leads to growing strategic initiatives by the service providers to grow its presence in the market, which is expected to drive the growth in the coming years. In January 2023, BioNTech SE collaborated with the UK government to provide clinical trials for modified mRNA immunotherapies for up to 10,000 patients by the end of 2030. In addition, it is focused on offering infectious disease vaccines and investment to increase its footprint in the UK market.

Furthermore, several industry players are launching new services to improve their penetration. For instance, in March 2024, Tampa General Hospital commenced the TGH Cancer Institute Phase I Cancer Research Unit at the main campus in Tampa. The aim of this Phase I Cancer Research Unit is to provide cancer patients with access to leading-edge research studies integrated with compassionate and comprehensive care.

Cancer Treatment Facilities Market Report Highlights:

  • In terms of treatment, the cancer surgery segment dominated the market with a revenue share of 34.12% in 2023. The development and increasing adoption of robotic surgery techniques is having a significant impact on the growth of the segment. However, chemotherapy services are the fastest-growing segment during the forecast period.
  • Based on the cancer type, the blood cancer segment accounted for the maximum revenue share in 2023. This growth is attributed to the increasing involvement of key companies in the R&D of blood cancer treatments globally.
  • Based on provider, the hospital segment accounted for the maximum revenue share in 2023 due to its advanced diagnostic and treatment capabilities in oncology departments.
  • Asia Pacific dominated the market in 2023 due to factors such as the growing cancer incidence, increasing demand for personalized care, and the rise in the development of healthcare infrastructure.
  • In May 2024, HCG (Healthcare Global Enterprises) opened new cancer care centers in North Bengaluru, adding a total of 125 beds. These strategically positioned facilities will provide a complete range of advanced cancer treatments, from diagnosis to personalized treatment plans.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Cancer Type
    • 1.2.3. Provider
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Volume Price Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing incidence of cancers
      • 3.2.1.2. Technology advancement
      • 3.2.1.3. Rising medical tourism
      • 3.2.1.4. Growing government investment in cancer treatment facility
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High initial investment cost to setup cancer treatment facility
      • 3.2.2.2. Stringent regulations for cancer treatment facility setup
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Cancer Treatment Facilities Market: Treatment Estimates & Trend Analysis

  • 4.1. Treatment Market Share, 2023 & 2030
  • 4.2. Treatment Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Bone Marrow Transplantation
    • 4.4.1. Bone marrow transplantation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Chemotherapy
    • 4.5.1. Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Radiation Therapy
    • 4.6.1. Radiation therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Hormone Therapy
    • 4.7.1. Hormone therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Immunotherapy
    • 4.8.1. Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.9. Cancer Surgery
    • 4.9.1. Cancer surgery market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cancer Treatment Facilities Market: Cancer Type Estimates & Trend Analysis

  • 5.1. Cancer Type Market Share, 2023 & 2030
  • 5.2. Cancer Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, by Cancer type, 2018 to 2030 (USD Million)
  • 5.4. Blood Cancer
    • 5.4.1. Blood cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Breast Cancer
    • 5.5.1. Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Prostate Cancer
    • 5.6.1. Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Gastrointestinal Cancer
    • 5.7.1. Gastrointestinal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8. Gynecologic Cancer
    • 5.8.1. Gynecologic cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.9. Respiratory/Lung Cancer
    • 5.9.1. Respiratory/Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.10. Other Cancer Types
    • 5.10.1. Other cancer types market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cancer Treatment Facilities Market: Provider Estimates & Trend Analysis

  • 6.1. Provider Market Share, 2023 & 2030
  • 6.2. Provider Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analyses, by Provider, 2018 to 2030 (USD Million)
  • 6.4. Cancer Centers
    • 6.4.1. Cancer centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Cancer Treatment Facilities Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. North America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamic
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive insights
      • 7.4.2.4. U.S. cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamic
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive insights
      • 7.4.3.4. Canada cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamic
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive insights
      • 7.4.4.4. Mexico cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamic
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive insights
      • 7.5.2.4. Germany cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. UK
      • 7.5.3.1. Key country dynamic
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive insights
      • 7.5.3.4. UK cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamic
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive insights
      • 7.5.4.4. France cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamic
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive insights
      • 7.5.5.4. Italy cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamic
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive insights
      • 7.5.6.4. Spain cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamic
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive insights
      • 7.5.7.4. Denmark cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamic
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive insights
      • 7.5.8.4. Sweden cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamic
      • 7.5.9.2. Regulatory framework
      • 7.5.9.3. Competitive insights
      • 7.5.9.4. Norway cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamic
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive insights
      • 7.6.2.4. Japan cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamic
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive insights
      • 7.6.3.4. China cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamic
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive insights
      • 7.6.4.4. India cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamic
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive insights
      • 7.6.5.4. South Korea cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key country dynamic
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive insights
      • 7.6.6.4. Australia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamic
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive insights
      • 7.6.7.4. Thailand cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamic
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive insights
      • 7.7.2.4. Brazil cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamic
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive insights
      • 7.7.3.4. Argentina cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamic
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive insights
      • 7.8.2.4. South Africa cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamic
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive insights
      • 7.8.3.4. Saudi Arabia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamic
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive insights
      • 7.8.4.4. UAE cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamic
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive insights
      • 7.8.5.4. Kuwait cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Compass Oncology
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Service benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. American Oncology Institute
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Service benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Mayo Foundation for Medical Education and Research (MFMER)
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Service benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. HCA International Limited
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Service benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. The Royal Marsden
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Service benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. National Cancer Instituteat the National Institutes of Health
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Service benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. Apollo Hospitals Enterprise Ltd.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Service benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Kokilaben Dhirubhai Ambani Hospital
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Service benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. HEALTHCARE GLOBAL ENTERPRISES LIMITED
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Service benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. The Johns Hopkins Hospital
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Service benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Tata Memorial Centre.
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Service benchmarking
      • 8.5.11.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 4 Global cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 5 Global cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 6 Global cancer treatment facilities market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 9 North America cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 10 North America cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 11 U.S. cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 U.S. cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 13 U.S. cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 14 Canada cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 15 Canada cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 16 Canada cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 17 Mexico cancer treatment facilities market, by teatment, 2018 - 2030 (USD Million)
  • Table 18 Mexico cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 19 Mexico cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 20 Europe cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 21 Europe cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 22 Europe cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 23 UK cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 24 UK cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 25 UK cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 26 Germany cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 Germany cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 28 Germany cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 29 France cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 30 France cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 31 France cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 32 Italy cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 33 Italy cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 34 Italy cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 35 Spain cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 Spain cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 37 Spain cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 38 Norway cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 39 Norway cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 40 Norway cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 41 Sweden cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 42 Sweden cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 43 Sweden cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 44 Denmark cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 45 Denmark cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 46 Denmark cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 51 Japan cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 52 Japan cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 53 Japan cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 54 China cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 55 China cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 56 China cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 57 India cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 58 India cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 59 India cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 60 Australia cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 61 Australia cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 62 Australia cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 63 South Korea cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 64 South Korea cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 65 South Korea cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 66 Thailand cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 67 Thailand cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 68 Thailand cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 69 Latin America cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 71 Latin America cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 72 Latin America cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 73 Brazil cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 74 Brazil cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 75 Brazil cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 76 Argentina cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 77 Argentina cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 78 Argentina cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 83 South Africa cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 84 South Africa cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 85 South Africa cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 89 UAE cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 90 UAE cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 91 UAE cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 92 Kuwait cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 93 Kuwait cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Cancer treatment facilities market: Treatment outlook and key takeaways
  • Fig. 17 Cancer treatment facilities market: Treatment movement analysis
  • Fig. 18 Bone marrow transplantation market revenue, 2018 - 2030 (USD Million)
  • Fig. 19 Chemotherapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 20 Radiation therapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 21 Hormone therapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 22 Immunotherapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 23 Cancer surgery market revenue, 2018 - 2030 (USD Million)
  • Fig. 24 Cancer treatment facilities market: Cancer type outlook and key takeaways
  • Fig. 25 Cancer treatment facilities market: Cancer type movement analysis
  • Fig. 26 Blood cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 27 Breast cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 28 Prostate cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 29 Gastrointestinal cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 30 Gynecologic cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 31 Respiratory/Lung cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 32 Other cancer types market revenue, 2018 - 2030 (USD Million)
  • Fig. 33 Cancer treatment facilities market: Provider outlook and key takeaways
  • Fig. 34 Cancer treatment facilities market: Provider movement analysis
  • Fig. 35 Cancer centers market revenue, 2018 - 2030 (USD Million)
  • Fig. 36 Hospitals market revenue, 2018 - 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Regional outlook, 2023 & 2030
  • Fig. 39 Cancer treatment facilities market: Region movement analysis
  • Fig. 40 North America cancer treatment facilities market, 2018-2030, (USD Million)
  • Fig. 41 US key country dynamics
  • Fig. 42 US cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 43 Canada key country dynamics
  • Fig. 44 Canada cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 45 Mexico key country dynamics
  • Fig. 46 Mexico cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 47 Europe cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 48 UK key country dynamic
  • Fig. 49 UK cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany key country dynamic
  • Fig. 51 Germany cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 52 France key country dynamic
  • Fig. 53 France cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 54 Italy key country dynamic
  • Fig. 55 Italy cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 56 Spain key country dynamic
  • Fig. 57 Spain cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark key country dynamic
  • Fig. 59 Denmark cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 60 Sweden key country dynamic
  • Fig. 61 Sweden cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 62 Norway key country dynamic
  • Fig. 63 Norway cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 65 China key country dynamic
  • Fig. 66 China cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 67 Japan key country dynamic
  • Fig. 68 Japan cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 69 India key country dynamic
  • Fig. 70 India cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 71 South Korea key country dynamic
  • Fig. 72 South Korea cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 73 Australia key country dynamic
  • Fig. 74 Australia cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 75 Thailand key country dynamic
  • Fig. 76 Thailand cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 77 Latin America cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil key country dynamic
  • Fig. 79 Brazil cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 80 Argentina key country dynamic
  • Fig. 81 Argentina cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 82 MEA cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 83 South Africa key country dynamic
  • Fig. 84 South Africa cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 85 Saudi Arabia key country dynamic
  • Fig. 86 Saudi Arabia cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 87 UAE key country dynamic
  • Fig. 88 UAE cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 89 Kuwait key country dynamic
  • Fig. 90 Kuwait cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 91 Company categorization
  • Fig. 92 Strategy mapping
  • Fig. 93 Company market position analysis